DE69501325D1 - Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe - Google Patents

Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe

Info

Publication number
DE69501325D1
DE69501325D1 DE69501325T DE69501325T DE69501325D1 DE 69501325 D1 DE69501325 D1 DE 69501325D1 DE 69501325 T DE69501325 T DE 69501325T DE 69501325 T DE69501325 T DE 69501325T DE 69501325 D1 DE69501325 D1 DE 69501325D1
Authority
DE
Germany
Prior art keywords
complexes
fatty acid
pct
carbon atoms
acid moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69501325T
Other languages
English (en)
Other versions
DE69501325T2 (de
Inventor
Morten Sloth Weidner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrosan ApS
Original Assignee
Morten Sloth Weidner
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8091955&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69501325(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Morten Sloth Weidner filed Critical Morten Sloth Weidner
Publication of DE69501325D1 publication Critical patent/DE69501325D1/de
Application granted granted Critical
Publication of DE69501325T2 publication Critical patent/DE69501325T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fats And Perfumes (AREA)
DE69501325T 1994-03-14 1995-03-14 Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe Expired - Lifetime DE69501325T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK29694 1994-03-14
PCT/DK1995/000118 WO1995025084A1 (en) 1994-03-14 1995-03-14 A method of rendering organic compounds soluble in fatty systems, novel chemical complexes of such compounds and various applications of the complexes

Publications (2)

Publication Number Publication Date
DE69501325D1 true DE69501325D1 (de) 1998-02-05
DE69501325T2 DE69501325T2 (de) 1998-09-03

Family

ID=8091955

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69501325T Expired - Lifetime DE69501325T2 (de) 1994-03-14 1995-03-14 Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe

Country Status (13)

Country Link
US (1) US6087391A (de)
EP (1) EP0750604B1 (de)
JP (1) JP3802927B2 (de)
CN (1) CN1114589C (de)
AT (1) ATE161527T1 (de)
AU (1) AU680355B2 (de)
BR (1) BR9507080A (de)
DE (1) DE69501325T2 (de)
ES (1) ES2113738T3 (de)
GR (1) GR3026479T3 (de)
HU (1) HU222373B1 (de)
RU (1) RU2145320C1 (de)
WO (1) WO1995025084A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2767062B1 (fr) * 1997-08-11 2000-03-17 Andre Pierre Morice Composition comprenant de la propolis
US7416749B2 (en) * 2000-06-12 2008-08-26 Access Business Group International Llc Dietary supplement and related method
US7438936B2 (en) * 2000-06-12 2008-10-21 Access Business Group International Llc Dietary supplement and related method
US7939115B2 (en) * 2000-06-12 2011-05-10 Access Business Group International Llc Dietary supplement and related method
KR100983802B1 (ko) * 2002-06-20 2010-09-27 아스션 더마톨로지 에이/에스 폴리히드록시알칸의 지방산 에스테르 및 피리미딘카르복시 유도체의 신규한 복합체
US20040195549A1 (en) * 2003-04-04 2004-10-07 Clifford Adams Lipid-soluble formulations containing mixtures of antioxidants
EP2192160B1 (de) * 2008-12-01 2016-08-17 Aquanova Ag Micellar integrierter Oxidationsschutz für natürliche Farbstoffe

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
EP0543943B1 (de) * 1990-08-13 1995-04-26 YESAIR, David W. Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien
AU9020991A (en) * 1990-11-12 1992-06-11 Fileco Antiviral use of a 2,6-di-t-butylphenol compound substituted in position 4, particularly in relation to herpesviruses and papillomaviruses

Also Published As

Publication number Publication date
EP0750604B1 (de) 1997-12-29
HUT76420A (en) 1997-08-28
JP3802927B2 (ja) 2006-08-02
AU680355B2 (en) 1997-07-24
CN1114589C (zh) 2003-07-16
GR3026479T3 (en) 1998-06-30
DE69501325T2 (de) 1998-09-03
AU1945995A (en) 1995-10-03
JPH09510224A (ja) 1997-10-14
HU9602513D0 (en) 1996-11-28
RU2145320C1 (ru) 2000-02-10
US6087391A (en) 2000-07-11
ES2113738T3 (es) 1998-05-01
EP0750604A1 (de) 1997-01-02
CN1143949A (zh) 1997-02-26
BR9507080A (pt) 1997-09-16
HU222373B1 (hu) 2003-06-28
WO1995025084A1 (en) 1995-09-21
ATE161527T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
BR0107069A (pt) Composição nutricional, usos de uma composição e de uma fórmula enriquecida de nutriente
ATE143570T1 (de) Zusammensetzungen zur oralen nahrungsmittelaufnahme mit verbessertem geschmack
EP1961312A3 (de) Mischung von mikrobiellen Ölen und deren Verwendungen
KR900002784A (ko) 항종양치료에 사용하기 위한 약제학적 결합제제
DE3684409D1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
GR3017282T3 (en) Novel arylpyridazines, their manufacture, use and medicaments containing them.
KR960016889A (ko) 뇌기능 개선제
HUT50842A (en) Process for producing new diphosphonic acid derivatives and pharmaceutical compositions comprising same
AU6964687A (en) Catalyst compositions
DE69109297D1 (de) Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
CA2054955A1 (fr) Composition cosmetique, pharmaceutique ou alimentaire comportant une dispersion de vesicules lipidiques
AU2274099A (en) Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
DE69501325T2 (de) Methode zur solubilisierung organischer verbindungen in lipophilen systemen ,neue chemische komplexe solcher verbindungen und verschiedene anwendungen dieser komplexe
GB8810173D0 (en) Pharmaceutical compositions with anti-cancer activity & method for treatment of cancer
MY109434A (en) Fluoroaliphatic dimer acid derivatives and use thereof
ES8406498A1 (es) Procedimiento de obtencion de complejos de platino (ii)-diamina
TW364905B (en) Lactone compound and process of production thereof
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
KR850700108A (ko) 항종양 의약 조성물 및 그의 제조 방법
ITRM910070A0 (it) Derivati degli acidi dicarbossilici aventi da sei a dodici atomi di carbonio ed impiego di tali derivati e degli acidi stessi per la preparazione di composizioni farmaceutiche atte all'alimentazione enterale parenterale.
HU913011D0 (en) Method for producing inhibitors of calcium ingestion
SE9702173D0 (sv) Nya kolhydrater och deras användning
MY105876A (en) Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer.
DE69215511D1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
SU1637326A1 (ru) Питательная среда для выращивания холерного вибриона

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: SLOTH-WEIDNER, MORTEN, VIRUM, DK

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WEIDNER, MORTEN SLOTH, VIRUM, DK

8327 Change in the person/name/address of the patent owner

Owner name: EUROVITA A/S, KARLSLUNDE, DK

8381 Inventor (new situation)

Free format text: WEIDNER, MORTEN SLOTH, VIRUM, DK